IRMD (iRadimed) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRMD iRadimed Corp IRMD
92 GF Score
Price $87.55
GF Value $65.80
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is iRadimed Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

IRMD vs AORT, TNDM, AVNS: Short Interest Comparison

For the Medical Devices subindustry, iRadimed's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iRadimed Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Short Interest distribution charts can be found below:

* The bar in red indicates where iRadimed's Short Interest falls into.


IRMD
92GF Score
iRadimed Corp IRMD
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is iRadimed (IRMD) Overvalued in 2026?

Based on GuruFocus' analysis, iRadimed stock appears to be overvalued. The current stock price of $87.55 is trading 33.1% above its estimated GF Value™ of $65.80. GuruFocus considers iRadimed to be Significantly Overvalued.

Key valuation signals for IRMD:

  • Short Interest:
  • GF Value™: $65.80 vs. price of $87.55 (33.1% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the IRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRadimed Business Description

Other Exchanges 46K:Germany
Address 12705 Ingenuity Drive, Orlando, FL, USA, 32826
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
92GF Score

Get the complete analysis for IRMD

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$87.55
Price
$65.80
GF Value